The 2015 Heart Rhythm Society Expert Consensus Statement, authored by Sheldon and colleagues, is the official cardiology reference document for diagnosing and managing postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. It is the document most cardiologists and electrophysiologists cite when they reach for a definition. Understanding what it says precisely — and what it does not say — matters because the gap between the document's actual language and how that language gets applied in clinic visits is often where patients get incorrectly dismissed or misclassified.
The consensus defines POTS as a sustained heart rate increase of 30 beats per minute or more within 10 minutes of standing or head-up tilt, in the absence of orthostatic hypotension, accompanied by chronic symptoms of orthostatic intolerance lasting at least six months. In adolescents aged 12 to 19, the threshold is 40 beats per minute rather than 30, acknowledging the higher resting sympathetic tone in this age group.
The absence-of-orthostatic-hypotension criterion is significant and frequently misunderstood. POTS is not defined by a blood pressure drop on standing. A patient whose blood pressure falls significantly on standing — defined as a drop of 20 mmHg systolic or 10 mmHg diastolic within three minutes — has orthostatic hypotension, which is a different condition. POTS patients typically maintain or even slightly increase their blood pressure while heart rate climbs. The two presentations can co-exist as separate mechanisms, but orthostatic hypotension alone is not POTS.
The six-month duration criterion matters clinically. Transient orthostatic tachycardia following deconditioning, illness, or acute dehydration does not qualify. The chronic nature of the condition is part of the definition, which means the diagnostic criteria are specifically designed to capture a persistent dysregulatory state, not a temporary compensation.
One of the most consequential statements in this document is the explicit clarification that syncope — fainting — is not a required feature of POTS and is not its defining characteristic. The name "postural orthostatic tachycardia syndrome" does not contain the word syncope. The defining feature is the tachycardia and the chronic orthostatic intolerance symptoms. Fainting is optional.
This matters because a substantial proportion of patients with POTS are told, sometimes by cardiologists, that they cannot have the condition because they do not faint. The word "syncope" in related conditions like vasovagal syncope creates confusion, and clinicians who conflate POTS with syncope conditions impose a diagnostic gate that the actual consensus document does not support. The document's language on this is not ambiguous.
The symptoms that do qualify under orthostatic intolerance include lightheadedness, palpitations, tremulousness, weakness, blurred vision, exercise intolerance, fatigue, and cognitive difficulty — what is often called brain fog. These are the symptoms the patient actually presents with. Many of them are symptoms that no individual specialist clinic treats as their primary domain, which is part of why POTS patients accumulate multiple specialist visits without a diagnosis.
The consensus addresses the relationship between POTS and vasovagal syncope explicitly, which is useful because the two conditions are frequently conflated and sometimes co-present in the same patient. The document frames them as distinct mechanisms. Vasovagal syncope involves a reflex-mediated event in which heart rate and blood pressure abruptly drop, producing loss of consciousness. POTS involves chronic orthostatic tachycardia without that reflex drop — at least as its primary mechanism.
When a POTS patient does experience syncope, the consensus specifies that the syncope should be evaluated as a potentially separate mechanism co-existing with POTS rather than assuming POTS caused the faint. However, this evaluation should occur only after excluding obvious precipitants: significant dehydration, beta blocker use, severe hypocapnia, or arrhythmia. The practical implication is that a clinician who sees a POTS patient faint should not automatically credit POTS as the explanation and stop investigating. The syncope mechanism may be distinct and may require separate characterization.
The 2015 consensus is a clinical reference document, not a mechanistic research synthesis. It does not address cerebral blood flow during orthostatic challenge. It does not discuss the role of CO₂ dynamics or hyperventilation in producing cerebral hypoperfusion. It does not differentiate the upstream subtypes of POTS — hyperadrenergic POTS, neuropathic POTS, hypovolemic POTS — in mechanistic depth. These are areas where the research literature has advanced substantially since 2015, and where the consensus document's silence should not be read as evidence that the mechanisms are unimportant.
The document also does not address the relationship between heart rate elevation and symptom severity, a question that subsequent research has addressed in ways that complicate the assumption that the diagnostic metric — heart rate increase — tracks the clinical severity of the condition.
Understanding the limits of this document is as important as understanding its content. It establishes the diagnostic floor: the minimum criteria that define the condition and distinguish it from related presentations. It does not provide a complete mechanistic account of why those criteria are met in any given patient, and it does not guide workup beyond the initial diagnostic threshold. The rest of the literature builds from here.
For patients navigating specialist encounters, the Heart Rhythm Society consensus carries institutional authority that individual papers do not. When a cardiologist is uncertain about diagnostic criteria, this is the document they will recognize. When a clinician incorrectly tells a patient that fainting is required for a POTS diagnosis, this is the document that refutes that claim in direct, unambiguous terms.
The consensus is also the document that formally distinguishes POTS from inappropriate sinus tachycardia, a condition defined by persistent elevated resting heart rate that is not postural. Patients with persistently elevated resting heart rate who are only symptomatic when upright, and whose heart rate drops significantly when supine, have POTS. Patients with persistently elevated heart rate in all positions, with symptoms regardless of posture, may have IST. The distinction affects both the mechanistic interpretation and the treatment approach.
What you now know, having read this document's actual language, is that the threshold for POTS diagnosis is lower than many specialists apply in practice, that fainting is explicitly excluded as a required feature, and that the six-month chronic symptom criterion is doing diagnostic work that the single tilt-table measurement cannot do alone. The number is not the whole diagnosis. The chronic, disabling orthostatic intolerance symptoms are the condition. The tachycardia is the measurable marker that cardiologists can quantify.
Creative Commons CC BY 4.0 — Website by @autonomicdrama